Exercise + TMS for Treatment Resistant Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how exercise might enhance the effects of regular TMS (a brain stimulation therapy) for individuals with treatment-resistant depression. By combining treadmill sessions with TMS, researchers aim to create a more favorable brain environment for TMS to work effectively. Participants will either engage in aerobic exercise (also known as physical activity, cardiovascular exercise, or fitness training) or watch videos before their TMS sessions. The study seeks adults already approved for TMS therapy who can safely participate in moderate exercise. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve depression treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that this combination of aerobic exercise and rTMS is safe for treating depression?
Research has shown that aerobic exercise, such as running or cycling, is generally safe and well-tolerated by most people. Studies have found that it can improve symptoms of depression without causing major side effects. Those who regularly engage in aerobic exercise often report feeling better both physically and mentally.
To ensure safety, supervision during exercise sessions is recommended. This involves regularly checking heart rate and blood pressure to keep them within safe limits. Supervision helps maintain exercise at a moderate level, which is safe for almost everyone.
Watching videos is a non-physical activity and is considered safe, similar to watching TV at home.
Overall, both aerobic exercise and video watching are safe activities for those considering joining this trial.12345Why are researchers excited about this trial?
Researchers are excited about combining aerobic exercise with transcranial magnetic stimulation (TMS) for treatment-resistant depression because it offers a non-pharmacological approach that could enhance the effectiveness of TMS. Unlike traditional antidepressants, which can take weeks to show benefits and often come with side effects, aerobic exercise can potentially improve mood and overall mental health quickly through natural endorphin release and increased blood flow to the brain. Additionally, incorporating educational video watching as a control condition helps researchers understand the specific impact of physical activity compared to passive engagement. This trial could pave the way for innovative treatments that provide more immediate relief for those who haven't responded to standard options.
What evidence suggests that this trial's treatments could be effective for treatment-resistant depression?
Research shows that aerobic exercise, one of the treatments in this trial, can help treat depression. Studies have found that activities like walking or jogging greatly reduce symptoms of depression. Aerobic exercise benefits mental health across various forms and intensity levels. It positively affects both short-term and long-term depression. The scientific idea is that it boosts brain activity and increases brain adaptability, which may help improve depression.24678
Are You a Good Fit for This Trial?
This trial is for adults over 18 with treatment-resistant depression who are approved for standard TMS therapy at Butler Hospital's clinic and can safely do moderate-intensity exercise.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 30 sessions of rTMS treatment, with either aerobic exercise or video watching prior to each session
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Aerobic Exercise
- Video Watching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Butler Hospital
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator